Picture of BioLargo logo

BLGO BioLargo Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsSpeculativeSmall CapNeutral

Annual cashflow statement for BioLargo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-9.55-10.7-11.4-9.7-6.89
Depreciation
Non-Cash Items5.276.616.935.422.69
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-0.0360.150.0250.0690.249
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-4.28-3.89-4.42-4.15-3.94
Capital Expenditures-0.029-0.058-0.035-0.023-0.034
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.10
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.029-0.058-0.035-0.123-0.034
Financing Cash Flow Items-0.040.357
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3.373.644.474.344.23
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.92-0.33500.0610.246

Or unlock with your email

Or unlock with your email